Detalhe da pesquisa
1.
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Blood
; 139(3): 413-423, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570876
2.
Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients.
Hematol Oncol
; 42(3): e3278, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38726682
3.
Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
Br J Haematol
; 202(2): 248-255, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129856
4.
SOHO State of the Art Updates and Next Questions Updates on Building Your CAR-T Cell Program.
Clin Lymphoma Myeloma Leuk
; 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643029
5.
Post-infusion PD-1+CD8+CAR-T cells identify patients responsive to CD19-CAR-T therapy in non-Hodgkin's lymphoma.
Blood Adv
; 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38607381
6.
Interleukin-23 production in dendritic cells is negatively regulated by protein phosphatase 2A.
Proc Natl Acad Sci U S A
; 107(18): 8340-5, 2010 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20404153
7.
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.
Blood Adv
; 7(16): 4528-4538, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026796
8.
Identifying aggressive subsets within diffuse large B-cell lymphoma: implications for treatment approach.
Expert Rev Anticancer Ther
; 22(5): 523-533, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390262
9.
Cellular Therapy Advances in Chronic Lymphocytic Leukemia and Richter's Syndrome.
Curr Probl Cancer
; 46(1): 100827, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991902
10.
Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma.
Blood Adv
; 6(4): 1255-1263, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34666347
11.
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma.
Blood Adv
; 6(7): 2035-2044, 2022 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196377
12.
Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantation.
Leuk Lymphoma
; 62(1): 86-94, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32933363
13.
Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma.
Blood Adv
; 5(18): 3623-3632, 2021 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34448831
14.
Therapeutic Updates for Relapsed and Refractory Classical Hodgkin Lymphoma.
Cancers (Basel)
; 12(10)2020 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33050054
15.
Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents.
Blood Adv
; 4(16): 3977-3989, 2020 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32841336
16.
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.
Clin Cancer Res
; 26(14): 3589-3596, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32198151
17.
Treatment of primary mediastinal B-cell lymphoma with dose-adjusted REPOCH during pregnancy.
Blood Adv
; 7(10): 2241-2244, 2023 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36287222
18.
Long-term remission in multiply relapsed enteropathy-associated T-cell lymphoma following CD30 CAR T-cell therapy.
Blood Adv
; 4(23): 5925-5928, 2020 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259598
19.